blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1448548

EP1448548 - PIPERIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5) [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.09.2010
Database last updated on 02.09.2024
Most recent event   Tooltip03.09.2010Application deemed to be withdrawnpublished on 06.10.2010  [2010/40]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2004/35]
Inventor(s)01 / Tucker, Howard
AstraZeneca R & D Alderley, Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
 [2004/35]
Application number, filing date02789054.012.11.2002
[2004/35]
WO2002SE02055
Priority number, dateSE2001000381815.11.2001         Original published format: SE 0103818
[2004/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03042205
Date:22.05.2003
Language:EN
[2003/21]
Type: A1 Application with search report 
No.:EP1448548
Date:25.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 22.05.2003 takes the place of the publication of the European patent application.
[2004/35]
Search report(s)International search report - published on:SE22.05.2003
ClassificationIPC:C07D401/06, C07D401/14, C07D403/06, C07D417/14, A61K31/4545, A61K31/496, A61P11/00, A61P17/00, A61P19/00, A61P29/00, A61P37/00
[2004/35]
CPC data not yet available
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/35]
Extension statesAL15.06.2004
LT15.06.2004
LV15.06.2004
MK15.06.2004
RO15.06.2004
SI15.06.2004
TitleGerman:PIPERIDINDERIVATE UND DEREN VERWENDUNG ALS MODULATOREN DER CHEMOKINREZEPTORAKTIVITÄT (INSBESONDERE VON CCR5)[2004/35]
English:PIPERIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5)[2004/35]
French:DERIVES DE LA PIPERIDINE ET LEUR UTILISATION COMME MODULATEURS DE L'ACTIVITE DU RECEPTEUR DE CHIMIOKINE (NOTAMMENT DE CCR5)[2004/35]
Entry into regional phase15.06.2004National basic fee paid 
15.06.2004Designation fee(s) paid 
15.06.2004Examination fee paid 
Examination procedure10.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: SE
15.06.2004Examination requested  [2004/35]
13.12.2007Despatch of a communication from the examining division (Time limit: M04)
10.04.2008Reply to a communication from the examining division
17.11.2008Despatch of a communication from the examining division (Time limit: M06)
13.05.2009Reply to a communication from the examining division
27.11.2009Despatch of a communication from the examining division (Time limit: M04)
08.04.2010Application deemed to be withdrawn, date of legal effect  [2010/40]
18.05.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/40]
Fees paidRenewal fee
30.11.2004Renewal fee patent year 03
30.11.2005Renewal fee patent year 04
30.11.2006Renewal fee patent year 05
30.11.2007Renewal fee patent year 06
28.03.2008Renewal fee patent year 07
30.11.2009Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9925686  (TEIJIN LTD [JP], et al);
 [X]EP1013276  (PFIZER [US], et al);
 [X]WO0114333  (ASTRAZENECA UK LTD [SE], et al);
 [XP]WO0187839  (ASTRAZENECA AB [SE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.